Sunday, February 16, 2014

Medicine Mandates

According to an online article in The Almagest, the FDA is issuing penalties to Indian drug manufacturers for adulterated and fake medicines.  The penalties have ranged in severity from large fines to outright bans.  Because 40% of U.S. consumer drugs are supplied by India, these penalties can have a major impact on the American marketplace.  Conversely, pharmaceutical manufacturing is a key sector in the Indian economy and any disruption can have major implications for the Indian workforce, as well (Francescangeli, 2014).

As discussed in class, the collapse of cultural, economic and political barrier is in evidence.  It is cultural in terms of social responsibility, economic in terms of the implications for both the American consumer and Indian manufacturers, and political in the FDA’s role in regulating Indian manufacturers.

There is a sovereignty question present here.  Traditionally, international relations were based upon sovereign interests, but in transnational social spaces the lines are blurred and unilateral policy across traditional national boundaries is no longer possible (Barber, 2002).  The regulatory power of the FDA is an assertion of American sovereignty, but such policy has a significant effect on the Indian labor force.  And in a world economy, the leverage of labor to protest policy is diminished as the labor market now competes globally (Sklair, 1999).

This is a manifestation of the idea of Glocalization, where the impact of the local must be understood in terms of its effect on the global and vice-versa (Beck, 2000).  In this case, the effects are two-way.  American values and consumer needs are legitimate in terms of safety and should be understood, as well as the impact of unilateral bans and resulting resent from India.  The two economies are tied closely together and issues of globalization need to be addressed in order to navigate the conflict described in the article.

References
Francescangeli, C. (2014, February). Medicines imported from India not safe: FDA. Retrieved from http://www.thealmagest.com/medicines-imported-india-safe-fda/10222.

Barber, B. (2002, January 3). Beyond Jihad vs. McWorld. The Nation. Retrieved from http://www.thenation.com/article/beyond-jihad-vs-mcworld

Beck, U. (2000). The world horizon opens up: On the sociology of globalization. In What is globalization? (pp. 17-30). Cambridge: Polity Press.

Sklair, L. (1999). Competing conceptions of globalization. Journal of World-System Research, 2, 143-163.